By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Kos Pharmaceutical Inc. 

1001 Brickell Bay Drive
25th Floor
Miami  Florida  33131  U.S.A.
Phone: 305-577-3464 Fax: 305-577-4596


Company News
Abbott Laboratories (ABT) Subsidiary Kos Pharmaceuticals (KOSP) Reaches $41M Settlement 12/8/2010 7:55:20 AM
Abbott Laboratories (ABT) Completes Acquisition Of Kos Pharmaceuticals (KOSP) 12/15/2006 10:38:30 AM
Abbott Laboratories (ABT)' Acquisition Of Kos Pharmaceuticals (KOSP)' Clears Antitrust Review 12/5/2006 10:41:40 AM
Abbott Laboratories (ABT) Commences Tender Offer For All Outstanding Shares Of Kos Pharmaceuticals (KOSP) 11/14/2006 2:38:36 PM
Kos Pharmaceuticals (KOSP) Reports A 17% Increase In Revenue, Earnings Per Share Of $0.71, And Solid Cash Flow From Operations 11/9/2006 11:46:11 AM
Kos Pharmaceuticals (KOSP) To Report Third Quarter Results On November 9, 2006 Conference Call At 8:30 A.M. ET 11/3/2006 11:06:04 AM
Merck & Co., Inc. (MRK) Revises Regulatory Filing Timeline For MK-0524B, An Investigational Fixed-Dose Combination Of MK-0524A And Simvastatin; Kos Pharmaceuticals (KOSP) Shares Rise On Merck Delay 9/29/2006 8:53:47 AM
The Day In Review: Merck & Co., Inc. (MRK) Gets European Approval Of Gardasil 9/22/2006 7:09:31 PM
Kos Pharmaceuticals (KOSP) Announces Overall Results For Two Phase III Trials Of Icatibant For The Treatment Of Hereditary Angioedema; Primary Endpoint Met In FAST-2 But Not Met In FAST-1 9/22/2006 9:14:27 AM
Kos Pharmaceuticals (KOSP) To Present At The UBS Warburg Global Life Sciences Conference 9/19/2006 12:23:53 PM